Nuria Navarro-Coy

1.9k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

Nuria Navarro-Coy is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Nuria Navarro-Coy has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Nuria Navarro-Coy's work include Multiple Myeloma Research and Treatments (6 papers), Spondyloarthritis Studies and Treatments (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Nuria Navarro-Coy is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Spondyloarthritis Studies and Treatments (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Nuria Navarro-Coy collaborates with scholars based in United Kingdom, Australia and Germany. Nuria Navarro-Coy's co-authors include Walter M. Gregory, Mark T. Drayson, Faith E. Davies, Roger G. Owen, Graham Jackson, Sue Bell, Gordon Cook, Gareth J. Morgan, Sylvia Feyler and Paul Emery and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Nuria Navarro-Coy

14 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

2015 329 citations Laura C. Coates, Anna R. Moverley et al. The Lancet profile →

Peers

Nuria Navarro-Coy

HEMAT

ONCOL

RHEUM

IMMUN

Edit Drescher United States

Raffaello Bertieri Italy

Kamel Laribi France

Nikolaos Kanellias Greece

Gabriella Sammarelli Italy

Antonietta Falcone Italy

Kendra Sweet United States

Nathalie Cambier France

Eva Löfvenberg Sweden

Maurizio Miglino Italy

Edit Drescher United States

Nuria Navarro-Coy

463 ×0.6

HEMAT

301 ×0.5

ONCOL

922 ×2.3

RHEUM

116 ×0.3

486 ×1.5

IMMUN

Citations per year, relative to Nuria Navarro-Coy Nuria Navarro-Coy (= 1×) peers Edit Drescher

Countries citing papers authored by Nuria Navarro-Coy

Since Specialization

Citations

This map shows the geographic impact of Nuria Navarro-Coy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuria Navarro-Coy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuria Navarro-Coy more than expected).

Fields of papers citing papers by Nuria Navarro-Coy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuria Navarro-Coy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuria Navarro-Coy. The network helps show where Nuria Navarro-Coy may publish in the future.

Co-authorship network of co-authors of Nuria Navarro-Coy

This figure shows the co-authorship network connecting the top 25 collaborators of Nuria Navarro-Coy. A scholar is included among the top collaborators of Nuria Navarro-Coy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuria Navarro-Coy. Nuria Navarro-Coy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Coates, Laura C., Anna R. Moverley, Lucy McParland, et al.. (2015). Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. The Lancet. 386(10012). 2489–2498. 329 indexed citations breakdown →

Hyde, T P, Helen L Craddock, Joanne Gray, et al.. (2014). A Randomised Controlled Trial of complete denture impression materials. Journal of Dentistry. 42(8). 895–901. 21 indexed citations

Coates, Laura C., Anna R. Moverley, Lucy McParland, et al.. (2014). Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a multicentre, open-label, randomised controlled trial. The Lancet. 383. S36–S36. 11 indexed citations

Coates, Laura C., Nuria Navarro-Coy, Sarah Brown, et al.. (2013). The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskeletal Disorders. 14(1). 101–101. 76 indexed citations

Rawstron, Andy C., J. A. Child, Ruth M. de Tute, et al.. (2013). Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study. Journal of Clinical Oncology. 31(20). 2540–2547. 285 indexed citations

Gray, Joanne, Nuria Navarro-Coy, Sue Pavitt, et al.. (2012). Improvdent: Improving dentures for patient benefit. A crossover randomised clinical trial comparing impression materials for complete dentures. BMC Oral Health. 12(1). 37–37. 7 indexed citations

Alcacer‐Pitarch, Begonya, Maya H Buch, Joanne Gray, et al.. (2012). Pressure and pain In Systemic sclerosis/Scleroderma - an evaluation of a simple intervention (PISCES): randomised controlled trial protocol. BMC Musculoskeletal Disorders. 13(1). 11–11. 12 indexed citations

Morgan, Gareth J., J. Anthony Child, Walter M. Gregory, et al.. (2011). Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial. The Lancet Oncology. 12(8). 743–752. 117 indexed citations

Morgan, Gareth J., Faith E. Davies, Walter M. Gregory, et al.. (2010). First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. The Lancet. 376(9757). 1989–1999. 407 indexed citations

10.

Morgan, Gareth J., Faith E. Davies, Walter M. Gregory, et al.. (2010). Thalidomide Maintenance Significantly Improves Progression-Free Survival (PFS) and Overall Survival (OS) of Myeloma Patients When Effective Relapse Treatments Are Used: MRC Myeloma IX Results. Blood. 116(21). 623–623. 12 indexed citations

11.

Child, J. A., Faith E. Davies, F. M. Ross, et al.. (2009). A546 MRC Myeloma IX: Preliminary Results from The Intensive Pathway Study. Clinical Lymphoma & Myeloma. 9. S84–S85.

12.

Morgan, Gareth J., Faith E. Davies, F. M. Ross, et al.. (2009). A346 Prospective Study of Serum FLC and Other M-Protein Assays: When and How to Measure Response?. Clinical Lymphoma & Myeloma. 9. S56–S56. 5 indexed citations

13.

Morgan, Gareth J., H. D. Jackson, Faith E. Davies, et al.. (2009). A547 MRC Myeloma IX: Preliminary Results from the Non-Intensive Study. Clinical Lymphoma & Myeloma. 9. S85–S85. 1 indexed citations

14.

Navarro-Coy, Nuria, Tim Hutchin, Emma L. Coghill, et al.. (2001). The relative contribution of mutations in the DFNB loci to congenital/early childhood non-syndromal sensorineural hearing impairment/deafness. Journal of Medical Genetics. 38(4). 2 indexed citations

15.

Hutchin, Tim, Nuria Navarro-Coy, Guy Van Camp, et al.. (2001). Multiple origins of the mtDNA 7472insC mutation associated with hearing loss and neurological dysfunction. European Journal of Human Genetics. 9(5). 385–387. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact